These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2471961

  • 1. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia.
    Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV.
    Prostate; 1989; 14(3):191-208. PubMed ID: 2471961
    [Abstract] [Full Text] [Related]

  • 2. Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma.
    Srkalovic G, Szende B, Redding TW, Groot K, Schally AV.
    Proc Soc Exp Biol Med; 1989 Dec; 192(3):209-18. PubMed ID: 2574866
    [Abstract] [Full Text] [Related]

  • 3. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M, Wittliff JL, Schally AV.
    J Clin Lab Anal; 1989 Dec; 3(3):137-47. PubMed ID: 2569034
    [Abstract] [Full Text] [Related]

  • 4. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
    Kadar T, Redding TW, Ben-David M, Schally AV.
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):890-4. PubMed ID: 2893378
    [Abstract] [Full Text] [Related]

  • 5. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
    Fekete M, Zalatnai A, Schally AV.
    Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204
    [Abstract] [Full Text] [Related]

  • 6. Membrane receptors for peptides in experimental and human pancreatic cancers.
    Fekete M, Zalatnai A, Comaru-Schally AM, Schally AV.
    Pancreas; 1989 May; 4(5):521-8. PubMed ID: 2573055
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV, Redding TW.
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR, Radulovic S, Groot K, Schally AV.
    Prostate; 1992 Oct; 20(4):269-80. PubMed ID: 1376910
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Int J Cancer; 1994 Oct 01; 59(1):51-5. PubMed ID: 7927904
    [Abstract] [Full Text] [Related]

  • 10. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.
    Srkalovic G, Wittliff JL, Schally AV.
    Cancer Res; 1990 Mar 15; 50(6):1841-6. PubMed ID: 2155060
    [Abstract] [Full Text] [Related]

  • 11. Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer.
    Srkalovic G, Schally AV, Wittliff JL, Day TG, Jenison EL.
    Int J Oncol; 1998 Mar 15; 12(3):489-98. PubMed ID: 9472084
    [Abstract] [Full Text] [Related]

  • 12. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV.
    Endocrinology; 1990 Dec 15; 127(6):3052-60. PubMed ID: 2174343
    [Abstract] [Full Text] [Related]

  • 13. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT.
    Cancer Res; 1992 May 01; 52(9):2538-44. PubMed ID: 1568223
    [Abstract] [Full Text] [Related]

  • 14. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.
    Lamharzi N, Halmos G, Jungwirth A, Schally AV.
    Int J Oncol; 1998 Sep 01; 13(3):429-35. PubMed ID: 9683774
    [Abstract] [Full Text] [Related]

  • 15. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
    Schally AV, Kook AI, Monje E, Redding TW, Paz-Bouza JI.
    Proc Natl Acad Sci U S A; 1986 Nov 01; 83(22):8764-8. PubMed ID: 2946045
    [Abstract] [Full Text] [Related]

  • 16. Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Pinski J, Halmos G, Szepeshazi K, Schally AV.
    Cancer; 1993 Dec 01; 72(11):3263-70. PubMed ID: 8242552
    [Abstract] [Full Text] [Related]

  • 17. Antitumor effects of analogs of LH-RH and somatostatin: experimental and clinical studies.
    Schally AV, Srkalovic G, Szende B, Redding TW, Janaky T, Juhasz A, Korkut E, Cai RZ, Szepeshazi K, Radulovic S.
    J Steroid Biochem Mol Biol; 1990 Dec 20; 37(6):1061-7. PubMed ID: 1981009
    [Abstract] [Full Text] [Related]

  • 18. Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination.
    Szepeshazi K, Milovanovic S, Lapis K, Groot K, Schally AV.
    Breast Cancer Res Treat; 1992 Dec 20; 21(3):181-92. PubMed ID: 1355375
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1981 Oct 20; 78(10):6509-12. PubMed ID: 6458815
    [Abstract] [Full Text] [Related]

  • 20. Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer.
    Kadar T, Ben-David M, Pontes JE, Fekete M, Schally AV.
    Prostate; 1988 Oct 20; 12(4):299-307. PubMed ID: 2455886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.